A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation
Abstract: Most myelodysplastic syndromes (MDS)-patients receive multiple red blood cell transfusions (RBCT). Transfusions may cause iron-related toxicity and mortality, influencing outcome after allogeneic HSCT. This prospective non-interventional study evaluated 222 MDS and CMML patients undergoing HSCT. Overall survival (OS), relapse-free survival (RFS), non-relapse mortality (NRM), and relapse incidence (RI) at 36 months were 52%, 44%, 25%, and 31%, respectively. Age, percentage of marrow blasts and severe comorbidities impacted OS. RFS was significantly associated with RBCT burden prior to HSCT (HR: 1.7; p = .02). High ferritin levels had a significant negative impact on OS and RI, but no impact on NRM. Administration of iron chelation therapy prior to HSCT did not influence the outcome, but early iron reduction after HSCT (started before 6 months) improved RFS significantly after transplantation (56% in the control group vs. 90% in the treated group, respectively; p = .04). This study illustrates the impact of RBCT and related parameters on HSCT-outcome. Patients with an expected prolonged survival after transplantation may benefit from early iron reduction therapy after transplantation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Leukemia & lymphoma. - 60, 10 (2019) , 2404-2414, ISSN: 1029-2403
- Keyword
-
Chelattherapie
Bluttransfusion
Myelodysplastisches Syndrom
- Event
-
Veröffentlichung
- (where)
-
Freiburg
- (who)
-
Universität
- (when)
-
2019
- Creator
-
Cremers, Eline M. P.
Witte, Theo de
Wreede, Liesbeth Cornelia de
Eikema, Diderik-Jan
Köster, Linda
Biezen, Anja van
Finke, Jürgen
Socié, Gerard
Beelen, Dietrich W.
Maertens, Johan
Nagler, Arnon
Kobbe, Guido
Ziagkos, Dimitris
Itälä‐Remes, Maija
Gedde-Dahl, Tobias
Sierra, Jorge
Niederwieser, Dietger
Ljungman, Per
Beguin, Yves
Ozkurt, Zubeyde Nur
Anagnostopoulos, Achilles
Jindra, Pavel
Robin, Marie
Kröger, Nicolaus
- DOI
-
10.1080/10428194.2019.1594215
- URN
-
urn:nbn:de:bsz:25-freidok-1512854
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Cremers, Eline M. P.
- Witte, Theo de
- Wreede, Liesbeth Cornelia de
- Eikema, Diderik-Jan
- Köster, Linda
- Biezen, Anja van
- Finke, Jürgen
- Socié, Gerard
- Beelen, Dietrich W.
- Maertens, Johan
- Nagler, Arnon
- Kobbe, Guido
- Ziagkos, Dimitris
- Itälä‐Remes, Maija
- Gedde-Dahl, Tobias
- Sierra, Jorge
- Niederwieser, Dietger
- Ljungman, Per
- Beguin, Yves
- Ozkurt, Zubeyde Nur
- Anagnostopoulos, Achilles
- Jindra, Pavel
- Robin, Marie
- Kröger, Nicolaus
- Universität
Time of origin
- 2019
Other Objects (12)
Allogeneic stem cell transplantation for patients age ≥ 70 years with myelodysplastic syndrome: a retrospective study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT
Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party
Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT
Zytomorphometrische Analyse von Speicheldrüsentumoren und verwandter Gewebe : eine computergestützte quantitative Analyse zytologischer Ausstrichpräparate
Molekulare Mechanismen der Entstehung von B-Zell-Lymphomen des Menschen
Ein solid-phase-Radioimmunoassay zum Nachweis des Epstein-Barr-Virus-assoziierten Frühantigen-Komplexes (Early Antigen)
Optimierung der Mobilisierung von hämatopoetischen Progenitorzellen mit G-CSF bei Patienten mit hämatologischen oder soliden Neoplasien
Informationsbroschüre für Patienten vor allogener Knochenmark-, Blutstammzelltransplantation
Haploidentical versus unrelated allogeneic stem cell transplantation for relapsed/refractory acute myeloid leukemia: a report on 1578 patients from the Acute Leukemia Working Party of the EBMT
Treosulfan compared with reduced‐intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial
Rabbit ATG/ATLG in preventing graft-versus-host disease after allogeneic stem cell transplantation: consensus-based recommendations by an international expert panel
Donor selection for a second allogeneic stem cell transplantation in AML patients relapsing after a first transplant: a study of the acute leukemia working party of EBMT
Allogeneic stem cell transplantation for patients age ≥ 70 years with myelodysplastic syndrome: a retrospective study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT
Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party
Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT
Zytomorphometrische Analyse von Speicheldrüsentumoren und verwandter Gewebe : eine computergestützte quantitative Analyse zytologischer Ausstrichpräparate
Molekulare Mechanismen der Entstehung von B-Zell-Lymphomen des Menschen
Ein solid-phase-Radioimmunoassay zum Nachweis des Epstein-Barr-Virus-assoziierten Frühantigen-Komplexes (Early Antigen)
Optimierung der Mobilisierung von hämatopoetischen Progenitorzellen mit G-CSF bei Patienten mit hämatologischen oder soliden Neoplasien
Informationsbroschüre für Patienten vor allogener Knochenmark-, Blutstammzelltransplantation
Haploidentical versus unrelated allogeneic stem cell transplantation for relapsed/refractory acute myeloid leukemia: a report on 1578 patients from the Acute Leukemia Working Party of the EBMT
Treosulfan compared with reduced‐intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial
Rabbit ATG/ATLG in preventing graft-versus-host disease after allogeneic stem cell transplantation: consensus-based recommendations by an international expert panel
Donor selection for a second allogeneic stem cell transplantation in AML patients relapsing after a first transplant: a study of the acute leukemia working party of EBMT
Allogeneic stem cell transplantation for patients age ≥ 70 years with myelodysplastic syndrome: a retrospective study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT
Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party
Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT
Zytomorphometrische Analyse von Speicheldrüsentumoren und verwandter Gewebe : eine computergestützte quantitative Analyse zytologischer Ausstrichpräparate
Molekulare Mechanismen der Entstehung von B-Zell-Lymphomen des Menschen
Ein solid-phase-Radioimmunoassay zum Nachweis des Epstein-Barr-Virus-assoziierten Frühantigen-Komplexes (Early Antigen)
Optimierung der Mobilisierung von hämatopoetischen Progenitorzellen mit G-CSF bei Patienten mit hämatologischen oder soliden Neoplasien
Informationsbroschüre für Patienten vor allogener Knochenmark-, Blutstammzelltransplantation
Haploidentical versus unrelated allogeneic stem cell transplantation for relapsed/refractory acute myeloid leukemia: a report on 1578 patients from the Acute Leukemia Working Party of the EBMT
Treosulfan compared with reduced‐intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial
Rabbit ATG/ATLG in preventing graft-versus-host disease after allogeneic stem cell transplantation: consensus-based recommendations by an international expert panel